IRulya Therapeutics (IRLA) Other Non-Current Assets (2018 - 2026)
IRulya Therapeutics (IRLA) recorded Other Assets of $78,000 in Q2 2026, down 99.3% from $11.22 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Other Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics reported Other Assets of $1.76 million, down 81.6% from FY2024.
- Annual Other Assets has a five-year compound annual growth rate of 114.2% (FY2020 to FY2025).
- Across earlier years, Other Assets came in at $9.58 million in FY2024 (+12.2%), $8.54 million in FY2023 and $194,000 in FY2021 (+397.4%).
- Quarterly Other Assets has ranged from $17,000 in Q3 2022 to $11.87 million in Q3 2025 over the past five years.
- On a year-over-year basis, Other Assets has declined for three consecutive quarters, with an average decline of 28.3% over the last seven quarters.
- Peak year-over-year performance for Other Assets in the last five years was growth of 397.4% in Q4 2021, against a decline of 99.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $78,000 (Q1 2026), $1.76 million (Q4 2025) and $11.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 10.02 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 78,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 11.22 Mn |
| Mar 31, 2025 | 9.95 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 8.80 Mn |
| Mar 31, 2024 | 8.47 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 194,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 145,000.00 |
| Mar 31, 2021 | 39,000.00 |
| Dec 31, 2020 | 39,000.00 |
| Sep 30, 2020 | 209,000.00 |
API Access
IRulya Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();